The themes Vericel is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
Built from Vericel Corporation’s own filings with the U.S. Securities and Exchange Commission (SEC). Figures are as reported, with per-share history restated onto today’s share basis. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.
$59.40+0.6%Nov 11 close
Figures through September 30, 2026, from the 10-Q filed November 5, 2026
Company outlook: revenue of $344M to $346M for Fiscal year 2026 — up 24.9% on a year earlier
Just reported
From Vericel's results release of November 5, 2026; its quarterly report has since been filed.
Actual
$85.4M
+26% y/y
+10% q/q
Guided
—
No guide given
Actual
$0.27
+170% y/y
Guided
—
No guide given
Actual
$12.2M
+253% y/y
Guided
—
No guide given
Full year 2026
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
Grade A
The band under the price shows the grade on each date, built only from filings that were public by then.
Showing 2 of 41 quarters of Vericel Corporation’s grade history. The other 39 go back to November 2016.